
Genevieve M. Boland MD PhD
Surgical Oncology (Other than Breast)
Surgical Oncology at MGH
Join to View Full Profile
55 Fruit St# 7BBoston, MA 02114
Phone+1 617-726-8290
Dr. Boland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2011 - 2014
- Mass General Brigham/Massachusetts General HospitalResidency, Surgery, 2006 - 2011
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2006
Certifications & Licensure
- MA State Medical License 2014 - 2027
- ME State Medical License 2020 - 2026
- NH State Medical License 2024 - 2024
- TX State Medical License 2011 - 2015
- American Board of Surgery Complex General Surgical Oncology
Publications & Presentations
PubMed
- ASO Visual Abstract: Genetic Factors Associated with Clinical Response in Melanoma Patients Treated with Talimogene Laherparepvec-A Single-Institution Retrospective An...Kailan Sierra-Davidson, Aikaterini Dedeilia, Aleigha Lawless, Tanya Sharova, Howard L Kaufman
Annals of Surgical Oncology. 2025-04-01 - Use of patient-derived organotypic tumor spheroids for testing of viral vector gene therapy in combination with checkpoint blockade.Ana Carolina M Domingues, Soraia B de Oliveira, Nayara G Tessarollo, Ana Paula Lepique, Otavio Rodrigues
Molecular Therapy. Oncology. 2025-03-20 - Cell states and neighborhoods in distinct clinical stages of primary and metastatic esophageal adenocarcinoma.Josephine Yates, Camille Mathey-Andrews, Jihye Park, Amanda Garza, Andréanne Gagné
Biorxiv. 2025-03-03
Journal Articles
- Publisher Correction: Robust Prediction of Response to Immune Checkpoint Blockade Therapy in Metastatic MelanomaGenevieve Boland, Ryan J Sullivan, Keith Flaherty, Nature
- Robust Prediction of Response to Immune Checkpoint Blockade Therapy in Metastatic MelanomaRyan J Sullivan, Genevieve Boland, Keith Flaherty, Nature
Press Mentions
- Ultrasensitive Test Detects, Serially Monitors Intact Virus Levels in Patients with COVID-19January 23rd, 2025
- Revolutionary Ultrasensitive Test Tracks Intact Virus Levels in COVID-19 Patients over TimeJanuary 22nd, 2025
- Ultrasensitive Test Detects and Serially Monitors Intact Virus Levels in COVID-19 PatientsJanuary 22nd, 2025
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: